Patent · US Expired

Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles

US6803055B2 · kind B2 · utility

36Cited by

62References

3Claims

0Family size

Assignees

Alkermes Controlled Therapeutics, Inc. · US
Janssen Pharmaceuticals, Inc. · BE

Inventors

Jean Mesens · Wechelderzande, BE
Michael E. Rickey · Morrow, US
Thomas J. Atkins · Wilmington, US

Key dates

Filing date	Feb 6, 2003
Grant date	Oct 12, 2004
Priority date	—
Expiry date	Feb 6, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Sustained-release microparticle composition. The microparticle composition can be formulated to provide multi-phasic release. In one aspect, the composition includes microparticles having more than one rate of release. In another aspect, the composition includes microparticles that exhibit diffusional release and microparticles that exhibit biodegradation release.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.